Rafael Holdings, Inc.
If you purchased Rafael Holdings, Inc. securities and would like to join the action, please click "Join This Action" below.
RAFAEL HOLDINGS MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE MERGER OF RAFAEL HOLDINGS, INC. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – RFL
June 21, 2021.
New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Rafael Holdings, Inc. (NYSE: RFL) and Rafael Pharmaceuticals, Inc. is fair to Rafael Holdings shareholders. In connection with the proposed merger, Rafael Pharmaceuticals shareholders will receive shares of Rafael Holdings Class B common stock amounting to approximately 48% of the currently outstanding capitalization of the company. Additional equity in the company will be issued in connection with anticipated financing and employment agreements, which will reduce the foregoing percentage proportionately.
The investigation concerns whether Rafael Holdings and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Rafael Holdings shareholders; and (2) disclose all material information necessary for Rafael Holdings shareholders to adequately assess and value the merger consideration. On behalf of Rafael Holdings shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.